UroGen Pharma Ltd. financial statements
UroGen Pharma Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 109.79M | 10-K |
| Net income | −USD 153.49M | 10-K |
| Cash and equivalents | USD 110.75M | 10-Q |
| Total debt | USD 125M | 10-K |
UroGen Pharma Ltd. financials on 6ix · UroGen Pharma Ltd. on 6ix